Physician profile
John A Douglas
NPI 1851391908
$2,334.56
in general payments reported to CMS, 2019-2025
14 companies · $699 in 2025
The $699 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $268 · 2020: $124 · 2021: $90.56 · 2022: $400 · 2023: $509 · 2024: $243 · 2025: $699.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,451.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,451.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,246.49 | 2022-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Bone Anchors With Arthroscopic Delivery System, Na |
| Stryker Corporation | $491.03 | 2019-2023 | Mako |
| Davol INC. | $134.97 | 2022 | |
| Medtronic, INC. | $124.83 | 2021-2024 | Intellis Adaptivestim |
| Ferring Pharmaceuticals INC. | $123.53 | 2019-2022 | |
| Depuy Synthes Sales INC. | $48.61 | 2020 | |
| Zimmer Biomet Holdings, INC. | $43.50 | 2025 | Tapestry |
| Boston Scientific Corporation | $31.50 | 2023-2024 | Wavewriter Alpha Prime 16 |
| Djo, LLC | $23.82 | 2020 | |
| Hartmann USA, INC. | $14.19 | 2024 | Colactive Plus 2x2 |
| Vertex Pharmaceuticals Incorporated | $14.05 | 2025 | |
| Pacira Therapeutics, INC. | $13.18 | 2019 | |
| Orthofix Medical, INC. | $12.51 | 2025 | Physio-Stim |
| Heron Therapeutics, INC. | $12.35 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Douglas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.